Dynamic Technology Lab’s Merrimack Pharmaceuticals MACK Stock Holding History
Bought
Maintained
Sold
Other funds holding MACK
NM
Dynamic Technology Lab's MACK Position: Q3 2018 in Review
Dynamic Technology Lab sold out of Merrimack Pharmaceuticals (MACK) in Q3 2018, closing a stake of 28,891 shares — an estimated $112K sold.
Dynamic Technology Lab first reported a position in MACK in Q3 2014 and held it in 5 quarters. The position peaked at $222K in Q3 2014. 63 funds tracked by Wall St. Rank hold MACK as of Q3 2018.
- Dynamic Technology Lab reported no remaining Merrimack Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
- Dynamic Technology Lab sold 28,891 Merrimack Pharmaceuticals shares in Q3 2018, an estimated $112K.
- Dynamic Technology Lab first reported a position in Merrimack Pharmaceuticals in Q3 2014 and held it in 5 quarters.
- Dynamic Technology Lab's Merrimack Pharmaceuticals position peaked at $222K in Q3 2014.
- 63 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals as of Q3 2018.
Based on Dynamic Technology Lab's 13F filing for Q3 2018, filed 14 Nov 2018.